
Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma
Author(s) -
Sheng Ye,
Youming Long,
Jian Rong,
Wen-Rui Xie
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.4739
Subject(s) - immunohistochemistry , cancer , medicine , chemotherapy , electrophoretic mobility shift assay , stage (stratigraphy) , carcinoma , survival analysis , nfkb1 , pathology , oncology , biology , gene expression , transcription factor , gene , paleontology , biochemistry
To detect the nuclear factor kappa B (NF-kappaB) condition in human stage IV gastric carcinoma patients and to explore the correlation between NF-kappaB activation and survival of these patients after chemotherapy.